terbutaline has been researched along with Airflow Obstruction, Chronic in 28 studies
Terbutaline: A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.
terbutaline : A member of the class of phenylethanolamines that is catechol substituted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study aimed to assess and compare the effectiveness of lidocaine and bronchodilator inhalation treatments for rapid cough suppression in patients with chronic obstructive pulmonary disease (COPD)." | 9.11 | Comparison of lidocaine and bronchodilator inhalation treatments for cough suppression in patients with chronic obstructive pulmonary disease. ( Chen, CC; Chen, YC; Chong, CF; Ma, HP; Wang, TL; Wu, YC, 2005) |
| "In COPD patients, additional administration of transdermal tulobuterol to inhaled tiotropium produced significant benefits in dyspnea and SGRQ score as well as pulmonary function." | 5.14 | Additive effects of transdermal tulobuterol to inhaled tiotropium in patients with COPD. ( Fukuchi, Y; Ichinose, M; Kubo, K; Mishima, M; Nagai, A; Nishimura, M; Seyama, K, 2010) |
| " We examined the effect of adding a long-acting anti-cholinergic agent (tiotropium) to a transdermal-type beta(2)-agonist (tulobuterol) on dyspnea as well as pulmonary function." | 5.12 | Improvement of pulmonary function and dyspnea by tiotropium in COPD patients using a transdermal beta(2)-agonist. ( Akamatsu, K; Hirano, T; Ichikawa, T; Ichinose, M; Maeda, S; Matsunaga, K; Minakata, Y; Miura, K; Nakanishi, M; Takahashi, T; Ueshima, K; Yamagata, T; Yamagata, Y; Yanagisawa, S, 2007) |
| "This study aimed to assess and compare the effectiveness of lidocaine and bronchodilator inhalation treatments for rapid cough suppression in patients with chronic obstructive pulmonary disease (COPD)." | 5.11 | Comparison of lidocaine and bronchodilator inhalation treatments for cough suppression in patients with chronic obstructive pulmonary disease. ( Chen, CC; Chen, YC; Chong, CF; Ma, HP; Wang, TL; Wu, YC, 2005) |
| "A total of 136 COPD patients with acute exacerbation were divided into the ipratropium bromide group (n=69) and the terbutaline group (n=67)." | 2.90 | Comparison of the efficacy of aerosol inhalation between the ipratropium bromide and terbutaline on the patients with AECOPD. ( Cui, R; Feng, Y; Wu, J; Xu, W; Zhu, J, 2019) |
| "In patients admitted to the ED for AECOPD requiring NIV, combination of nebulized IB and terbutaline did not reduce hospital admission and need to ICU care." | 2.90 | Nebulized Terbutaline and Ipratropium Bromide Versus Terbutaline Alone in Acute Exacerbation of Chronic Obstructive Pulmonary Disease Requiring Noninvasive Ventilation: A Randomized Double-blind Controlled Trial. ( Belguith, A; Beltaief, K; Boubaker, H; Bouida, W; Boukef, R; Fakhfakh, M; Grissa, MH; Marzouk, MB; Methamem, M; Msolli, MA; Nouira, S; Sekma, A; Zorgati, A, 2019) |
| "Treatment-naïve patients with COPD (n = 36) were prospectively treated with two kinds of LABA--inhaled salmeterol and transdermal tulobuterol patch--for 12 weeks in crossover study, and changes in pulmonary function data and 6-minute walk distance (6 MWD) were compared between groups stratified by the CysGlyGln." | 2.77 | β2-adrenergic receptor haplotype may be associated with susceptibility to desensitization to long-acting β2-agonists in COPD patients. ( Kawate, E; Mochizuki, H; Nanjo, Y; Takahashi, H; Tsuda, Y; Yamazaki, M, 2012) |
| "Chronic obstructive pulmonary disease (COPD) is a syndrome of chronic progressive airflow limitation as a result of chronic inflammation of the airways and lung parenchyma." | 2.73 | Atomization inhalation of terbutaline and budesonide efficiently improved immunity and lung function of AECOPD patients. ( Li, X; Wei, L; Xiong, G; Xu, L, 2008) |
| "The airway inflammation of chronic obstructive pulmonary disease (COPD) demonstrates a poor response to the anti-inflammatory actions of corticosteroids." | 2.73 | Anti-inflammatory effects and clinical efficacy of theophylline and tulobuterol in mild-to-moderate chronic obstructive pulmonary disease. ( Haruta, Y; Hattori, N; Ishikawa, N; Iwamoto, H; Kanehara, M; Kohno, N; Shiota, N; Taooka, Y; Tomoda, Y; Yokoyama, A, 2008) |
| "Transdermal beta 2-agonist tulobuterol showed an improvement in FEV1, FVC and IC after dosing compared with those at baseline." | 2.73 | Comparison of bronchodilatory properties of transdermal and inhaled long-acting beta 2-agonists. ( Akamatsu, K; Hirano, T; Ichikawa, T; Ichinose, M; Matsunaga, K; Minakata, Y; Nakanishi, M; Sugiura, H; Ueshima, K; Yamagata, T; Yanagisawa, S, 2008) |
| "Treatment of COPD patients with TP is more effective than with theophylline." | 2.73 | Clinical efficacy of the transdermal tulobuterol patch in patients with chronic obstructive pulmonary disease: a comparison with slow-release theophylline. ( Aizawa, H; Gohara, R; Ichiki, M; Iwanaga, T; Kawayama, T; Kinoshita, M; Koga, H; Minami, S; Nishiyama, M; Sueyasu, Y, 2008) |
| "Clinically stable COPD patients (age > or = 40 years, postbronchodilator FEV1/FVC <70%, and postbronchodilator FEV1 <80% predicted) were enrolled in a multicenter, open-label randomized study." | 2.71 | Clinical efficacy and safety of transdermal tulobuterol in the treatment of stable COPD: an open-label comparison with inhaled salmeterol. ( Aizawa, H; Fukuchi, Y; Hirata, K; Ichinose, M; Kubo, K; Nagai, A; Nishimura, M; Seyama, K, 2005) |
| "Changing PA behavior in COPD patients requires an interdisciplinary approach involving specialists in respiratory medicine, rehabilitation, social, and behavioral sciences." | 2.58 | Improvement of physical activity in chronic obstructive pulmonary disease by pulmonary rehabilitation and pharmacological treatment. ( Iwakura, M; Satake, M; Sato, S; Shioya, T; Takahashi, H; Terui, Y; Uemura, S, 2018) |
| "For the acute COPD studies, one was double-blind and randomised, one was single-blind and randomised, and one was open-label." | 2.45 | Use of dry powder inhalers in acute exacerbations of asthma and COPD. ( Borgström, L; Ingelf, J; Selroos, O, 2009) |
| " Our study aimed to investigate the clinical value of N-acetylcysteine (NAC) combined with terbutaline sulfate in the treatment of COPD in elderly people, and its effect on the apoptosis/anti-apoptosis mechanism." | 1.56 | Clinical value of N-acetylcysteine combined with terbutaline sulfate in elderly patients with chronic obstructive pulmonary disease and its effect on apoptosis/anti-apoptosis mechanism. ( Lin, J; Sun, Y; Xie, M; Zhang, L; Zhou, Q, 2020) |
| " Specifically, the results show that FGF10 haploinsufficiency affects lung function measures providing a model for a dosage sensitive effect of FGF10 in the development of COPD." | 1.37 | Fibroblast growth factor 10 haploinsufficiency causes chronic obstructive pulmonary disease. ( Badhai, J; Bergendal, B; Blomstrand, P; Brange, CS; Brunmark, C; Dahl, N; Håkansson, HF; Klar, J, 2011) |
| " The relative lung and systemic bioavailability of terbutaline from Bricanyl Turbuhaler when used by healthy subjects and COPD patients were determined after one and two inhalations at slow and fast inhalation flows using a novel urinary terbutaline pharmacokinetic method." | 1.36 | Emitted dose and lung deposition of inhaled terbutaline from Turbuhaler at different conditions. ( Abdelrahim, ME, 2010) |
| "Ninety-eight chronic obstructive pulmonary disease (COPD) patients were submitted to a respiratory function test on two different days." | 1.34 | The bronchodilator test in chronic obstructive pulmonary disease: interpretation methods. ( Almagro, P; Heredia, JL; Quintana, S; Rodríguez-Carballeira, M; Rué, M, 2007) |
| "Patients with chronic obstructive pulmonary disease (COPD) may be difficult to stabilize with standard inhaled and oral medication." | 1.32 | [Self-Management of Anti-Obstructive Therapy for Severe COPD with a Subcutaneous Terbutaline Pump]. ( Bauer, TT; De Zeeuw, J; Duchna, HW; Ehren, M; Grootoonk, S; Schultze-Werninghaus, G, 2003) |
| "Wheezing is a common clinical finding in patients with asthma and COPD during episodes of severe airway obstruction, and can also be heard in normal subjects during forced expiratory maneuvers; however, the properties of wheezing are difficult to perceive and quantify during auscultation." | 1.31 | Detection of wheezing during maximal forced exhalation in patients with obstructed airways. ( Fiz, JA; García, MA; Homs, A; Izquierdo, J; Jané, R; Morera, J, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 14 (50.00) | 29.6817 |
| 2010's | 13 (46.43) | 24.3611 |
| 2020's | 1 (3.57) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, W | 1 |
| Wu, J | 1 |
| Feng, Y | 1 |
| Zhu, J | 1 |
| Cui, R | 1 |
| Zhou, Q | 1 |
| Zhang, L | 1 |
| Sun, Y | 1 |
| Xie, M | 1 |
| Lin, J | 1 |
| Ogasawara, T | 1 |
| Sakata, J | 1 |
| Aoshima, Y | 1 |
| Tanaka, K | 1 |
| Yano, T | 1 |
| Kasamatsu, N | 1 |
| Shioya, T | 1 |
| Sato, S | 1 |
| Iwakura, M | 1 |
| Takahashi, H | 4 |
| Terui, Y | 1 |
| Uemura, S | 1 |
| Satake, M | 1 |
| Beltaief, K | 1 |
| Msolli, MA | 1 |
| Zorgati, A | 1 |
| Sekma, A | 1 |
| Fakhfakh, M | 1 |
| Marzouk, MB | 1 |
| Boubaker, H | 1 |
| Grissa, MH | 1 |
| Methamem, M | 1 |
| Boukef, R | 1 |
| Belguith, A | 1 |
| Bouida, W | 1 |
| Nouira, S | 1 |
| Gueho, F | 1 |
| Beaune, S | 1 |
| Devillier, P | 1 |
| Urien, S | 1 |
| Faisy, C | 1 |
| Xiong, G | 1 |
| Xu, L | 1 |
| Wei, L | 1 |
| Li, X | 1 |
| Kanehara, M | 1 |
| Yokoyama, A | 1 |
| Tomoda, Y | 1 |
| Shiota, N | 1 |
| Iwamoto, H | 1 |
| Ishikawa, N | 1 |
| Taooka, Y | 1 |
| Haruta, Y | 1 |
| Hattori, N | 1 |
| Kohno, N | 1 |
| Selroos, O | 1 |
| Borgström, L | 1 |
| Ingelf, J | 1 |
| Sugawara, T | 1 |
| Nanjo, Y | 3 |
| Yamazaki, M | 2 |
| Higashihara, K | 1 |
| Tsuda, Y | 2 |
| Mochizuki, H | 3 |
| Noguchi, T | 1 |
| Ichinose, M | 5 |
| Seyama, K | 2 |
| Nishimura, M | 2 |
| Fukuchi, Y | 3 |
| Nagai, A | 2 |
| Mishima, M | 1 |
| Kubo, K | 2 |
| Abdelrahim, ME | 1 |
| Płusa, T | 1 |
| Abe, T | 1 |
| Setoguchi, Y | 1 |
| Kono, Y | 1 |
| Togashi, Y | 1 |
| Sugiyama, S | 1 |
| Tanakadate, M | 1 |
| Soeda, S | 1 |
| Nakai, M | 1 |
| Sugiyama, N | 1 |
| Fujiwara, A | 1 |
| Yamaguchi, K | 1 |
| Yamaguchi, A | 1 |
| Kurita, N | 1 |
| Klar, J | 1 |
| Blomstrand, P | 1 |
| Brunmark, C | 1 |
| Badhai, J | 1 |
| Håkansson, HF | 1 |
| Brange, CS | 1 |
| Bergendal, B | 1 |
| Dahl, N | 1 |
| Tamura, G | 1 |
| Miyamoto, T | 1 |
| Kawate, E | 1 |
| Fiz, JA | 1 |
| Jané, R | 1 |
| Homs, A | 1 |
| Izquierdo, J | 1 |
| García, MA | 1 |
| Morera, J | 1 |
| Grootoonk, S | 1 |
| Schultze-Werninghaus, G | 1 |
| Ehren, M | 1 |
| De Zeeuw, J | 1 |
| Duchna, HW | 1 |
| Bauer, TT | 1 |
| Botting, C | 1 |
| Sutherland, M | 1 |
| Wells, E | 1 |
| Town, I | 1 |
| Sainsbury, R | 1 |
| Toop, L | 1 |
| Chong, CF | 1 |
| Chen, CC | 1 |
| Ma, HP | 1 |
| Wu, YC | 1 |
| Chen, YC | 1 |
| Wang, TL | 1 |
| Campbell, M | 1 |
| Eliraz, A | 1 |
| Johansson, G | 1 |
| Tornling, G | 1 |
| Nihlén, U | 1 |
| Bengtsson, T | 1 |
| Rabe, KF | 1 |
| Hirata, K | 1 |
| Aizawa, H | 2 |
| Rodríguez-Carballeira, M | 1 |
| Heredia, JL | 1 |
| Rué, M | 1 |
| Quintana, S | 1 |
| Almagro, P | 1 |
| Akamatsu, K | 2 |
| Yamagata, T | 2 |
| Takahashi, T | 1 |
| Miura, K | 1 |
| Maeda, S | 1 |
| Yamagata, Y | 1 |
| Ichikawa, T | 2 |
| Yanagisawa, S | 2 |
| Ueshima, K | 2 |
| Hirano, T | 2 |
| Nakanishi, M | 2 |
| Matsunaga, K | 2 |
| Minakata, Y | 2 |
| Sugiura, H | 1 |
| Minami, S | 1 |
| Kawayama, T | 1 |
| Ichiki, M | 1 |
| Nishiyama, M | 1 |
| Sueyasu, Y | 1 |
| Gohara, R | 1 |
| Kinoshita, M | 1 |
| Koga, H | 1 |
| Iwanaga, T | 1 |
3 reviews available for terbutaline and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Improvement of physical activity in chronic obstructive pulmonary disease by pulmonary rehabilitation and pharmacological treatment.
Topics: Adrenergic beta-2 Receptor Agonists; Behavior; Counseling; Delayed-Action Preparations; Drug Therapy | 2018 |
Use of dry powder inhalers in acute exacerbations of asthma and COPD.
Topics: Adrenergic beta-Agonists; Albuterol; Asthma; Bronchodilator Agents; Disease Progression; Ethanolamin | 2009 |
Transdermal tulobuterol patch, a long-actingβ(2)-agonist.
Topics: Adrenergic beta-Agonists; Asthma; Bronchodilator Agents; Drug Approval; Evidence-Based Medicine; Hum | 2012 |
16 trials available for terbutaline and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Comparison of the efficacy of aerosol inhalation between the ipratropium bromide and terbutaline on the patients with AECOPD.
Topics: Aged; Bronchodilator Agents; Female; Humans; Ipratropium; Male; Middle Aged; Pulmonary Disease, Chro | 2019 |
Bronchodilator Effect of Tiotropium via Respimat
Topics: Administration, Inhalation; Aged; Bronchodilator Agents; Cross-Over Studies; Female; Forced Expirato | 2017 |
Nebulized Terbutaline and Ipratropium Bromide Versus Terbutaline Alone in Acute Exacerbation of Chronic Obstructive Pulmonary Disease Requiring Noninvasive Ventilation: A Randomized Double-blind Controlled Trial.
Topics: Acute Disease; Administration, Inhalation; Bronchodilator Agents; Double-Blind Method; Drug Therapy, | 2019 |
Atomization inhalation of terbutaline and budesonide efficiently improved immunity and lung function of AECOPD patients.
Topics: Administration, Inhalation; Aged; Bronchial Hyperreactivity; Bronchodilator Agents; Budesonide; C-Re | 2008 |
Anti-inflammatory effects and clinical efficacy of theophylline and tulobuterol in mild-to-moderate chronic obstructive pulmonary disease.
Topics: Administration, Cutaneous; Adrenergic beta-Agonists; Aged; Anti-Inflammatory Agents, Non-Steroidal; | 2008 |
Comparison of adherence and efficacy between inhaled salmeterol and transdermal tulobuterol patch in elderly patients with chronic obstructive pulmonary disorder.
Topics: Administration, Cutaneous; Administration, Inhalation; Aged; Albuterol; Bronchodilator Agents; Cross | 2009 |
Additive effects of transdermal tulobuterol to inhaled tiotropium in patients with COPD.
Topics: Administration, Cutaneous; Administration, Inhalation; Aged; Bronchodilator Agents; Dose-Response Re | 2010 |
Effects of inhaled tiotropium plus transdermal tulobuterol versus tiotropium alone on impulse oscillation system (IOS)-assessed measures of peripheral airway resistance and reactance, lung function and quality of life in patients with COPD: a randomized c
Topics: Administration, Cutaneous; Administration, Inhalation; Aged; Aged, 80 and over; Airway Resistance; B | 2011 |
β2-adrenergic receptor haplotype may be associated with susceptibility to desensitization to long-acting β2-agonists in COPD patients.
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Aged; Albuterol; Cross-Over Studies | 2012 |
Better adherence to a transdermal tulobuterol patch than inhaled salmeterol in elderly chronic obstructive pulmonary disease patients.
Topics: Administration, Cutaneous; Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Adrenerg | 2013 |
Comparison of lidocaine and bronchodilator inhalation treatments for cough suppression in patients with chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Aged; Aged, 80 and over; Antitussive Agents; Bronchodilator Agents; Coug | 2005 |
Formoterol for maintenance and as-needed treatment of chronic obstructive pulmonary disease.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Adult; Aged; Aged, 80 and over; Analysis of Varia | 2005 |
Clinical efficacy and safety of transdermal tulobuterol in the treatment of stable COPD: an open-label comparison with inhaled salmeterol.
Topics: Administration, Cutaneous; Administration, Inhalation; Adult; Aged; Albuterol; Bronchodilator Agents | 2005 |
Improvement of pulmonary function and dyspnea by tiotropium in COPD patients using a transdermal beta(2)-agonist.
Topics: Administration, Cutaneous; Administration, Inhalation; Adrenergic beta-Agonists; Aged; Bronchodilato | 2007 |
Comparison of bronchodilatory properties of transdermal and inhaled long-acting beta 2-agonists.
Topics: Administration, Cutaneous; Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Aged; Al | 2008 |
Clinical efficacy of the transdermal tulobuterol patch in patients with chronic obstructive pulmonary disease: a comparison with slow-release theophylline.
Topics: Activities of Daily Living; Administration, Cutaneous; Aged; Aged, 80 and over; Bronchodilator Agent | 2008 |
9 other studies available for terbutaline and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Clinical value of N-acetylcysteine combined with terbutaline sulfate in elderly patients with chronic obstructive pulmonary disease and its effect on apoptosis/anti-apoptosis mechanism.
Topics: Acetylcysteine; Aged; Apoptosis; Humans; Oxidative Stress; Pulmonary Disease, Chronic Obstructive; T | 2020 |
Modeling the effectiveness of nebulized terbutaline for decompensated chronic obstructive pulmonary disease patients in the emergency department.
Topics: Administration, Inhalation; Aged; Aged, 80 and over; Bronchodilator Agents; Emergency Service, Hospi | 2016 |
Emitted dose and lung deposition of inhaled terbutaline from Turbuhaler at different conditions.
Topics: Administration, Inhalation; Adult; Analysis of Variance; Biological Availability; Bronchodilator Age | 2010 |
[Agonists of beta2 adrenergic receptor in the therapy of obstructive diseases].
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Albuterol; Arrhythmias, Cardiac; Card | 2010 |
Fibroblast growth factor 10 haploinsufficiency causes chronic obstructive pulmonary disease.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Animals; Female; Fibroblast Growth Factor 10; Forced | 2011 |
Detection of wheezing during maximal forced exhalation in patients with obstructed airways.
Topics: Analysis of Variance; Anthropometry; Asthma; Bronchodilator Agents; Case-Control Studies; Female; Fo | 2002 |
[Self-Management of Anti-Obstructive Therapy for Severe COPD with a Subcutaneous Terbutaline Pump].
Topics: Adult; Bronchodilator Agents; Humans; Infusion Pumps, Implantable; Male; Pulmonary Disease, Chronic | 2003 |
The use of inhaled and related respiratory medications in Christchurch rest homes.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Aged; Aged, 80 and ov | 2003 |
The bronchodilator test in chronic obstructive pulmonary disease: interpretation methods.
Topics: Aged; Bronchial Provocation Tests; Bronchodilator Agents; Data Interpretation, Statistical; Female; | 2007 |